ArticleAnnals of medicine2023

First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study.

Yahua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.